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Letter to the Editor
Comparison of natural killer activity during the first and
second halves of the menstrual cycle in women
Sir - A reduction in natural killer (NK) activity has
been observed both experimentally, in animals, by
treatment with 17-beta-oestradiol (Hanna &
Schneider, 1983; Holbrook et al., 1981; Milisauskas
et al., 1981; Oldham, 1982; Seaman et al., 1978),
and in women, between the first and second halves
of the menstrual cycle and between pre- and post-
menopausal levels (White et al., 1982). These results
suggest the possibility of hormonal regulation of
NK activity, whose depression could facilitate the
development of malignant tumours. In order to
verify this hypothesis, NK activity was determined
for a group of women during the first and second
halves of their menstrual cycle, i.e. before and after
the physiological peak for 17-beta-oestradiol, in
order to detect any variations. The study
population consisted of 13 women aged 29-39 years
(mean, 35 years) who were not taking any
hormonal contraceptive and who had a regular
cycle duration of 28-31 days (mean, 29 days). NK
activity was determined during a single cycle for
each woman, on Day 7+1 and on Day 23+1. NK
activity was measured by the conventional
technique, using K562 cells as targets. Briefly, cells
were cultured in a suspension of enriched RPMI
medium. The target cells are labelled with 100-
150 uCi of "Cr sodium chromate and adjusted to
10icellsml-'. Effector cells were incubated for 4h
with 100, of the suspension of labelled target cells
in microtitre plates at 37°C in an atmosphere of
5% CO2 in air. The percentage of specific lysis was
calculated by the following formula:
% specific lysis=ratio of experimental
lysis-minimal lysis: maximum lysis-minimum
lysis, using effector cell/target cell ratios of 3:1, 6: 1,
12:1, 25:1, 50:1 and 100:1.
No significant variation in NK activity was seen
between the first and second halves of the menstrual
cycle for these 13 women (Figure 1). All results were
within the normal limits defined by our laboratory.
With an effector cell/target cell ratio of 50:1, intra-
individual variations in NK activity between the
first and second halves of the cycle were minimal
(Figure 2).
The exact nature of cells responsible for NK
activity, their physiological role and their regulation
remain subject to controversy (Oldham, 1982).
Experimentally, treatment with 17-beta-oestradiol
has been shown to induce a marked reduction in
NK activity. Using a tumour model in the mouse,
this fall in NK activity has been associated with an
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Figure 1 NK activity with various effector cell/target
cell ratios: Pp, first half of the menstrual cycle (O); P2,
second half of the menstrual cycle (V).
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Figure 2 Variation in NK activity between the first
and second halves of the menstrual cycle for an
effector cell/target cell ratio of 50:1. P, first half of
the menstrual cycle (V); P2, second half of the
menstrual cycle (El).
increase in pulmonary metastases (Hanna &
Schneider, 1983). Under these same experimental
conditions, the spleens of these mice were found to
contain a Thy-i-negative/Ia-negative cell population
capable of suppressing NEK activity in non-treated
animals (Milisauskas et al., 1983). In vitro
incubation of human leukocytes with various
steroid hormones (oestradiol, progesterone,
testosterone) has not, however, been found to
reduce NK activity (Holbrook et al., 1983).
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The physiological role of steroid hormones, and
17-beta-oestradiol in particular, on NK activity thus
remains to be proved. We did not observe any
significant variation between the first and second
halves of the menstrual cycle, in contrast to the
results for the control population in a study
conducted on patients with a benign or malignant
breast pathology (White et al., 1982). In this study,
however, controls were divided into two groups and
were tested either in the first or second half of their
cycle, but no intra-individual tests were performed;
this may explain the difference with our own
findings.
In our opinion, in the present state of knowledge,
it is difficult to attribute a physiological role to
modulation of NK activity by oestradiol or to
implicate such modulation in the process of
carcinogenesis in women.
Yours, etc.,
A. Thyss, C. Caldani, C. Bourcier, G. Benita & M.
Schneider.
Centre Antoine-Lacassagne, Nice, France.
Editorial note: These results are of interest because
they fail to confirm the earlier observation of White
et al. (1982). However the question of the possible
cyclic variation in NK activity has still not been
adequately answered. What is required is a detailed
examination of NK activity in relation to the entire
cycle. Because of the day-to-day variation that
occurs in this type of test a much larger number of
observations may be required to produce an
unambiguous result.
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